Abbott Laboratories (MEX:ABT) PE Ratio: 24.44 (As of Jun. 25, 2026) — 32% Below Median


MEX:ABT Abbott Laboratories MEX:ABT
81 GF Score
Price MXN1,605.00
GF Value MXN2,296.73
Valuation Significantly Undervalued
View Full Analysis

What is Abbott Laboratories PE Ratio?

Abbott Laboratories MEX:ABT +1.26% 81 PE Ratio is 24.44 as of Jun. 25, 2026, which is 32% below its 10-year median of 36.00. GuruFocus rates MEX:ABT with a GF Score™ of 81/100 and a GF Value™ of MXN2,296.73 (Significantly Undervalued).

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-06-25), Abbott Laboratories's share price is MXN1605.00. Abbott Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN65.67. Therefore, Abbott Laboratories's PE Ratio for today is 24.44.

During the past 13 years, Abbott Laboratories's highest PE Ratio was 253.08. The lowest was 14.68. And the median was 36.00.

Abbott Laboratories's EPS (Diluted) for the three months ended in Mar. 2026 was MXN11.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN65.67.

As of today (2026-06-25), Abbott Laboratories's share price is MXN1605.00. Abbott Laboratories's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was MXN95.53. Therefore, Abbott Laboratories's PE Ratio without NRI ratio for today is 16.80.

During the past 13 years, Abbott Laboratories's highest PE Ratio without NRI was 36.81. The lowest was 16.18. And the median was 24.43.

Abbott Laboratories's EPS without NRI for the three months ended in Mar. 2026 was MXN20.74. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was MXN95.53.

During the past 12 months, Abbott Laboratories's average EPS without NRI Growth Rate was 17.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was -1.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 3.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 11.60% per year.

During the past 13 years, Abbott Laboratories's highest 3-Year average EPS without NRI Growth Rate was 40.90% per year. The lowest was -37.00% per year. And the median was 10.00% per year.

Abbott Laboratories's EPS (Basic) for the three months ended in Mar. 2026 was MXN11.18. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN66.04.

Back to Basics: PE Ratio


Abbott Laboratories  (MEX:ABT) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Abbott Laboratories PE Ratio Related Terms


Abbott Laboratories PE Ratio Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories PE Ratio Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.72 28.08 33.76 14.80 33.68

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.20 17.04 16.78 33.68 28.76

MEX:ABT vs SYK, MDT, BSX: PE Ratio Comparison

For the Medical Devices subindustry, Abbott Laboratories's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's PE Ratio distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's PE Ratio falls into.


MEX:ABT
81GF Score
Abbott Laboratories MEX:ABT
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Abbott Laboratories's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=1605.00/65.673
=24.44

Abbott Laboratories's Share Price of today is MXN1605.00.
Abbott Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN65.67.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 24.44 mean?
Abbott Laboratories (MEX:ABT) has a PE Ratio of 24.44 as of Jun. 25, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Abbott Laboratories and its competitors. This is 32% below median its historical median of 36.00. Over the past decade, Abbott Laboratories' PE Ratio has ranged from 14.68 to 253.08.
Is Abbott Laboratories' PE Ratio too high?
Abbott Laboratories' current PE Ratio of 24.44 is 32% below median its 10-year median of 36.00. Over the past 10 years, this metric has ranged from a low of 14.68 to a high of 253.08. Overall, Abbott Laboratories has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' PE Ratio compare to SYK and MDT?
Abbott Laboratories' PE Ratio of 24.44 can be compared against companies in the Medical Devices & Instruments industry. Historically, Abbott Laboratories' own PE Ratio has ranged from 14.68 to 253.08 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Medical Devices & Instruments company?
A good PE Ratio depends on the Medical Devices & Instruments industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current PE Ratio is 24.44, which is 32% below median its own 10-year median of 36.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (MEX:ABT) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN2,296.73, compared to a current price of MXN1,605.00 — trading 30.1% below its estimated fair value. The current PE Ratio is 24.44, which is 32% below median its 10-year median of 36.00. Abbott Laboratories' overall GF Score™ is 81/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Abbott Laboratories (MEX:ABT), the current PE Ratio is 24.44 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (MEX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of MXN1,605.00 is trading 30.1% below its estimated GF Value™ of MXN2,296.73. GuruFocus considers Abbott Laboratories to be Significantly Undervalued.

Key valuation signals for MEX:ABT:

  • PE Ratio: 24.44 (32% below median its 10-year median of 36.00)
  • GF Value™: MXN2,296.73 vs. price of MXN1,605.00 (30.1% below fair value)
  • GF Score™: 81/100

No single metric tells the full story. See the MEX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
81GF Score

Get the complete analysis for MEX:ABT

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,605.00
Price
MXN2,296.73
GF Value